O17 - Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations: LOW-RISK MYELODYSPLASTIC SYNDROMES (MDS) WITHOUT MUTATIONS ARE AS GOOD AS IDIOPATHIC CYTOPENIA OF UNDETERMINED SIGNIFICANCE (ICUS)

Autor: Polprasert, C., Niparuck, P., Rattanathammethee, T., Chuncharunee, S., Kobbualkee, S., Songserm, K., Suksusut, A., Trithiphen, S., Lanamtieng, T., Kongkiatkamon, S., Bunworasate, U., Rojnuckarin, P.

Publikováno v: In Leukemia Research September 2021 108 Supplement

Safety of the second dose of the ChAdOx1 nCoV-19 vaccine in people with persistent anti-platelet factor 4 antibodies.

Autor: Uaprasert N; Department of Medicine Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial Hospital Thai Red Cross Society Bangkok Thailand.; Research Unit in Translational Hematology Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial Hospital Thai Red Cross Society Bangkok Thailand., Trithiphen S; Department of Medicine Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial Hospital Thai Red Cross Society Bangkok Thailand., Sukperm A; Department of Medicine Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial Hospital Thai Red Cross Society Bangkok Thailand.; Research Unit in Translational Hematology Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial Hospital Thai Red Cross Society Bangkok Thailand., Akkawat B; Department of Medicine Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial Hospital Thai Red Cross Society Bangkok Thailand.; Research Unit in Translational Hematology Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial Hospital Thai Red Cross Society Bangkok Thailand., Watanaboonyongcharoen P; Department of Laboratory Medicine Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial Hospital Thai Red Cross Society Bangkok Thailand., Vichitratchaneekorn R; Department of Laboratory Medicine Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial Hospital Thai Red Cross Society Bangkok Thailand., Tongbai T; Department of Radiology Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial Hospital Thai Red Cross Society Bangkok Thailand., Jantarabenjakul W; Division of Infectious Diseases Department of Pediatrics Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial Hospital Thai Red Cross Society Bangkok Thailand., Paitoonpong L; Division of Infectious Diseases Department of Medicine Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial Hospital Thai Red Cross Society Bangkok Thailand., Rojnuckarin P; Department of Medicine Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial Hospital Thai Red Cross Society Bangkok Thailand.; Research Unit in Translational Hematology Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial Hospital Thai Red Cross Society Bangkok Thailand.

Publikováno v: Research and practice in thrombosis and haemostasis [Res Pract Thromb Haemost] 2021 Nov 21; Vol. 5 (8), pp. e12625. Date of Electronic Publication: 2021 Nov 21 (Print Publication: 2021).

Efficacy and safety of CAR-T therapy targeting CLL1 in patients with extramedullary diseases of acute myeloid leukemia.

Autor: Zhao, Yifan¹ (AUTHOR), Bai, Xue¹ (AUTHOR), Guo, Shujing¹ (AUTHOR), Zhang, Xiaomei² (AUTHOR), Liu, Jile¹ (AUTHOR), Zhao, Mohan¹ (AUTHOR), Xie, Tianle² (AUTHOR), Meng, Haotian² (AUTHOR), Zhang, Yu³ (AUTHOR), He, Xiaoyuan³ (AUTHOR), Zhao, Mingfeng³ (AUTHOR) mingfengzhao@sina.com

Publikováno v: Journal of Translational Medicine. 10/2/2024, Vol. 22 Issue 1, p1-12. 12p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Outcomes of allogeneic hematopoietic stem cell transplantation versus intensive chemotherapy in patients with myeloid sarcoma: a nationwide representative multicenter study.

Autor: Sun J; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.; Collaborative Innovation Centre of Hematology, Peking University, Beijing, China.; National Clinical Research Centre for Hematologic Disease, Beijing, China., Zhang YC; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China., Wei J; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China., Xu YJ; Department of Hematology, Xiangya Hospital, Central South University, Changsha, Hunan, China., Zhang Y; Department of Hematology, Xiangya Hospital, Central South University, Changsha, Hunan, China., Li YH; Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China., Wu AQ; Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China., Fan L; Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China., Zhu Y; Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China., Liu FQ; Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China., Jiang ZX; Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China., Liu C; Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China., Jiang M; Department of Hematology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, China., Qu JH; Department of Hematology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, China., He PC; Department of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China., Wang J; Department of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China., Huang XB; Department of Hematology, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China., Xiao R; Department of Hematology, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China., Gao SJ; Department of Hematology, The First Hospital of Jilin University, Changchun, Jilin, China., Guo Q; Department of Hematology, The First Hospital of Jilin University, Changchun, Jilin, China., Wang SB; Department of Hematology, 920th Hospital of Joint Logistics Support Force, Kunming, Yunnan, China., Li XP; Department of Hematology, 920th Hospital of Joint Logistics Support Force, Kunming, Yunnan, China., Fan SJ; Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China., Sun LL; Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China., Xu LP; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.; Collaborative Innovation Centre of Hematology, Peking University, Beijing, China.; National Clinical Research Centre for Hematologic Disease, Beijing, China., Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.; Collaborative Innovation Centre of Hematology, Peking University, Beijing, China.; National Clinical Research Centre for Hematologic Disease, Beijing, China., Zhang XH; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China. zhangxh@bjmu.edu.cn.; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China. zhangxh@bjmu.edu.cn.; Collaborative Innovation Centre of Hematology, Peking University, Beijing, China. zhangxh@bjmu.edu.cn.; National Clinical Research Centre for Hematologic Disease, Beijing, China. zhangxh@bjmu.edu.cn.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2024 Dec 02. Date of Electronic Publication: 2024 Dec 02.